Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

On 14 Dec, Mr Gilles Garachon, the French Ambassador to Thailand, arrived at Mae Sot in Thailand to present France’s highest award, l'Ordre National de la Légion d’honneur, to Professor François Nosten, Head of MORU’s Shoklo Malaria Research Unit (SMRU). The award is in recognition of Professsor Nosten's work over three decades fighting malaria.

Composite photo of the celebration of Francois Nosten receiving the Legion d'Honneur

Guests representing many SMRU partners who contributed to this award attended the ceremony including: Eh Ka Lu Shwe Oo from the Karen Department Health and Welfare (KDHW), Dr Cynthia Maung from the Mae Tao Clinic, Maw Ronnatrai, the former director of Mae Sot Hospital, Maw Jirapong Authaisin from the Mae Ra Mat Hospital, and representatives from Thai Public Health departments. Nick White and Nick Day represented MORU and many SMRU colleagues also attended.

The festivities later moved to the SMRU office with three generations of staff attending, and many taking turns to say how they enjoyed working with François over the years.

Please join us in giving your heartiest congratulations to François and the SMRU team for this well-deserved honour.

- With thanks to Dr Rose McGready for text and to Nick Day, Stephane Ribrault, Jordi Landier and Suphak Nosten for photos

Similar stories

Antimalarial chemoprophylaxis for forest goers could help accelerate malaria elimination in Cambodia

Giving people antimalarials during and after visiting the forest reduced their risk of contracting malaria 6-fold, and could be the missing piece towards eliminating malaria in Asia-Pacific and South America, say Mahidol and Oxford University researchers in a study published in The Lancet Infectious Diseases.

Four CTMGH researchers awarded full professorships

We are delighted to announce that four of our researchers have been awarded the title of Professor, in recognition of their research achievements, contribution to teaching, and contribution to the general work of the Nuffield Department of Medicine, University of Oxford.

INTERBIO-21st study findings could help predict infants at risk of obesity

Fetal abdomen growth and the mother’s blood fat metabolites very early in pregnancy influence a child’s weight, body fat, vision and neurodevelopment at 2 years of age

Using mathematical modelling to fight malaria

Researchers have created a mathematical model to predict genetic resistance to antimalarial drugs in Africa to manage one of the biggest threats to global malarial control.

MORU hepatitis work focusses on preventing mother-to-child transmission, high-at-risk populations, and remote communities

MORU Tropical Health Network researchers in Southeast Asia study various aspects of hepatitis B and C, infections that can lead to chronic liver diseases, and complications like liver cancer or cirrhosis. Researchers at MOCRU work on treatment for hepatitis C, a frequent opportunistic infection in HIV patients. MORU’s Clinical Pharmacology conducts two trials on possible treatments of hepatitis C. Hepatitis B is frequently transmitted from mother to child at birth, and SMRU researchers study mothers’ knowledge and behaviour, as well as prevention.

Incomplete reporting of COVID-19 disease severity criteria compromises meta-analysis

Patients affected by COVID-19 should be treated according to the severity of their disease. However, not all key national or international organisations define severity in the same way. This imprecision in severity assessment compromises the validity of some therapeutic recommendations. Using individual patient data would better guide and improve therapeutic recommendations for COVID-19.